SGN-B6A

· Seagen (a wholly owned subsidiary of Pfizer)

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGN-B6A, covering 2025-12-15 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer [Phase 3]